Role of Vitamin B12 and Folic Acid in Treatment of Alzheimer's Disease: a Meta-analysis of Randomized Control Trials

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2024 May 3

PMID 38700503

Authors

Chih-Ying Lee

Lung Chan

Chaur-Jong Hu

Chien-Tai Hong

Jia-Hung Chen

Affiliations

Soon will be listed here.

Abstract

Vitamin B12 and folic acid could reduce blood homocysteine levels, which was thought to slow down the progression of Alzheimer's disease (AD), but previous studies regarding the effect of vitamin B12 and folic acid in treatment of AD have not reached conclusive results. We searched PubMed and Embase until January 12, 2023. Only randomized control trials involving participants clearly diagnosed with AD and who received vitamin B12 and folic acid were enrolled. Five studies that met the criteria were selected for inclusion in the meta-analysis. Changes in cognitive function were measured based on either the Mini-Mental State Examination (MMSE) or the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog). Changes in daily life function and the level of blood homocysteine were also investigated. After a 6-month treatment, administration of vitamin B12 and folic acid improved the MMSE scores more than placebo did (SMD = 0.21, 95% CI = 0.01 to 0.32, = 0.04) but did not significantly affect ADAS-Cog scores (SMD = 0.06, 95% CI = -0.22 to 0.33, = 0.68) or measures of daily life function. Blood homocysteine levels were significantly decreased after vitamin B12 and folic acid treatment. Participants with AD who received 6 months of vitamin B12 and folic acid supplementation had better MMSE scores but had no difference in ADAS-Cog scores. Daily life function did not improve after treatment.

Citing Articles

Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases.

Orywal K, Socha K, Iwaniuk P, Kaczynski P, Farhan J, Zon W Int J Mol Sci. 2025; 26(3).

PMID: 39941101 PMC: 11818229. DOI: 10.3390/ijms26031333.

DNA methylation, histone acetylation in the regulation of memory and its modulation during aging.

Singh P, Paramanik V Front Aging. 2025; 5():1480932.

PMID: 39835300 PMC: 11743476. DOI: 10.3389/fragi.2024.1480932.

Folic Acid Prevents High-Fat Diet-Induced Postpartum Weight Retention in Rats, Which Is Associated with a Reduction in Endoplasmic Reticulum Stress-Mediated Hepatic Lipogenesis.

Zhang H, Zhang L, Zhao X, Ma Y, Sun D, Bai Y Nutrients. 2025; 16(24.

PMID: 39770997 PMC: 11676124. DOI: 10.3390/nu16244377.

Association between serum folate levels and migraine or severe headaches: A nationwide cross-sectional study.

Luwen H, Ping C, Qing-Rong O, Lei X, Linlin L, Yu M Medicine (Baltimore). 2024; 103(45):e40458.

PMID: 39533580 PMC: 11557034. DOI: 10.1097/MD.0000000000040458.

Exploring the Impact of Folic Acid Supplementation and Vitamin B12 Deficiency on Maternal and Fetal Outcomes in Pregnant Women with Celiac Disease.

Lev L, Petersen K, Roberts J, Kupferer K, Werder S Nutrients. 2024; 16(18).

PMID: 39339794 PMC: 11435006. DOI: 10.3390/nu16183194.

References

Sjoberg B, Anderstam B, Suliman M, Alvestrand A . Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD. Am J Kidney Dis. 2005; 47(1):60-71. DOI: 10.1053/j.ajkd.2005.09.032. View

Selhub J . Homocysteine metabolism. Annu Rev Nutr. 1999; 19:217-46. DOI: 10.1146/annurev.nutr.19.1.217. View

Yaffe K, Weston A, Graff-Radford N, Satterfield S, Simonsick E, Younkin S . Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA. 2011; 305(3):261-6. PMC: 3108075. DOI: 10.1001/jama.2010.1995. View

Wan X, Wang W, Liu J, Tong T . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135. PMC: 4383202. DOI: 10.1186/1471-2288-14-135. View

Refsum H, Ueland P, Nygard O, Vollset S . Homocysteine and cardiovascular disease. Annu Rev Med. 1998; 49:31-62. DOI: 10.1146/annurev.med.49.1.31. View

Durga J, van Boxtel M, Schouten E, Kok F, Jolles J, Katan M . Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007; 369(9557):208-16. DOI: 10.1016/S0140-6736(07)60109-3. View

Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y . Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial. Mediators Inflamm. 2016; 2016:5912146. PMC: 4909909. DOI: 10.1155/2016/5912146. View

Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B . Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone. 2012; 51(3):376-82. DOI: 10.1016/j.bone.2012.05.024. View

Liu A, Chang R, Pearce R, Gentleman S . Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Acta Neuropathol. 2015; 129(4):527-40. PMC: 4366544. DOI: 10.1007/s00401-015-1392-5. View

10.

van der Zwaluw N, Dhonukshe-Rutten R, van Wijngaarden J, Brouwer-Brolsma E, van de Rest O, In t Veld P . Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology. 2014; 83(23):2158-66. DOI: 10.1212/WNL.0000000000001050. View

11.

. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(5):459-480. PMC: 6459001. DOI: 10.1016/S1474-4422(18)30499-X. View

12.

Dong B, Wu R . Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis. Clin Neurol Neurosurg. 2019; 188:105587. DOI: 10.1016/j.clineuro.2019.105587. View

13.

Lacosta A, Insua D, Badi H, Pesini P, Sarasa M . Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains. J Alzheimers Dis. 2017; 58(3):661-667. DOI: 10.3233/JAD-170163. View

14.

Shen L, Ji H . Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses. J Alzheimers Dis. 2015; 46(3):777-90. DOI: 10.3233/JAD-150140. View

15.

Smach M, Jacob N, Golmard J, Charfeddine B, Lammouchi T, Ben Othman L . Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011; 65(5):270-8. DOI: 10.1159/000326301. View

16.

Cao Q, Tan C, Xu W, Hu H, Cao X, Dong Q . The Prevalence of Dementia: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2019; 73(3):1157-1166. DOI: 10.3233/JAD-191092. View

17.

Bell R, Zlokovic B . Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009; 118(1):103-13. PMC: 2853006. DOI: 10.1007/s00401-009-0522-3. View

18.

Smith A, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A . Homocysteine and Dementia: An International Consensus Statement. J Alzheimers Dis. 2018; 62(2):561-570. PMC: 5836397. DOI: 10.3233/JAD-171042. View

19.

Kurz C, Walker L, Rauchmann B, Perneczky R . Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies. Neuropathol Appl Neurobiol. 2021; 48(3):e12782. DOI: 10.1111/nan.12782. View

20.

Li W, Liu H, Yu M, Zhang X, Zhang M, Wilson J . Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice. J Nutr Biochem. 2015; 26(8):883-91. DOI: 10.1016/j.jnutbio.2015.03.009. View